×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 0505 Post Marketing Safety Surveillance
Session Chair(s)
Ivy Wang
Associate Director, Safety Surveillance & Risk Management
Pfizer, China
Speaker(s)
Evidence Triggered and Evidence Based - Thinking of Postmarking Drug Safety Issues (CN&EN)
Dayou WANG
Huashan Hospital, Fudan University, China
Signal Detection during Post-marketing Surveillance(CN&EN)
Howe Li
Tigermed, China
CMO
Have an account?